ClinicalTrials.gov
public full text
Public Domain
Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy
In this feasibility study, bronchoscopy will be combined with fluorescence molecular imaging using the near-infrared fluorescence (NIRF) tracer bevacizumab-800CW for assessment of pulmonary lesions and/or lymph nodes considered to be malignant.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer#1371740
- Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung#1074107
- nCLE For Diagnosis Of Peripheral Lung Nodules By Robotic Navigational Bronchoscopy#1094160
- The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum.#453000
- Comparative Performance of Robotic, Electromagnetic Navigation and Fluoroscopy Drives Optimal Diagnostic Strategy for Peripheral Pulmonary Lesions#856344
Record · ID 1295373
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive